Teijin Pharma Counts On Gout Drug For Global Expansion
This article was originally published in PharmAsia News
Executive Summary
Japan's Teijin Pharma plans to become a global player in the pharmaceutical industry with its Feburic (febuxostat) treatment for gout and hyperuricemia